News

Fermelanta Raises $13.8M Series A to Scale Microbial Production of Plant Metabolites

Japan-based Fermelanta secured JPY2 billion ($13.8 million) to advance R&D, enhance lab-to-pilot scale-up, and expand partnerships with CDMOs for microbial synthesis of plant-derived compounds, including morphine.

Shattuck Labs raises up to $103M to fund therapeutic antibody development

The funding will support Phase 1 and multiple Phase 2 trials of SL-325, an antibody designed to block the DR3/TL1A pathway with the potential to improve treatment for Crohn’s disease, ulcerative colitis, and other inflammatory conditions.

26 August 2025 | Investment

iNtRON Bio Files Patents for IMPA™ Gene Editing Platform Targeting Pasteurella Bacteriophages

iNtRON Bio has filed two patents for its IMPA™ platform, which combines CRISPR-Cas9 and recombination-based methods to engineer Pasteurella bacteriophages. The technology enables modular phages with diverse payloads for applications in gene editing, protein labeling, and capsid engineering.

26 August 2025 | Market Development

SOHM Advances ABBIE Gene Editing Platform with Breakthrough in Human Cell Modification

SOHM announced that its ABBIE version 2 platform, equipped with an enhanced dCas12a domain, has successfully modified cultured human cells, marking a key step toward commercial-ready gene editing technology and strengthening the company’s strategic partnership and licensing prospects

26 August 2025 | Market Development

Noblis Sends DNA Data Storage and Synthetic Biology Experiments to the ISS

The mission includes Helix Horizons, a DNA-based data storage system to test ultra-stable archives in space, and ScIPS, a synthetic microbial consortia platform designed to enable sustainable nutrition and adaptive biomanufacturing for deep space missions

25 August 2025 | Market Development

Levelle Nutrition Launches Cycle Syncing Protein with Helaina’s Fermented Lactoferrin

The U.S.-based company introduced a protein powder formulated with Helaina’s effera™, a precision-fermented, human-identical lactoferrin, to support women’s nutritional needs across the menstrual cycle.

25 August 2025 | Product Launch

Corbion and BRAIN Biotech Partner on Biobased Antimicrobial Development

A collaboration to develop novel biobased antimicrobial compounds and derivatives, combining BRAIN’s expertise in enzyme and microbial strain technologies with Corbion’s preservation knowledge and scale-up capabilities to advance natural food preservation solutions

25 August 2025 | Collaboration

Atlantic Fish Co. Secures $305K NSF SBIR Grant to Advance Cultivated Seafood

The Raleigh-based startup will use the funding to scale production of cultivated white fish, aiming to provide a sustainable alternative amid rising seafood demand and pressures from global overfishing.

Industry leaders use Knowledge Hub to explore 763+ Synthetic Biology news

Gain unparalleled insights, and drive your innovation forward.

Let’s shape tomorrow, today!